Last reviewed · How we verify
NCT04528511: BENEFIT-AMI
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
trial testing Continuous Electronic Monitor in Atrial Fibrillation New Onset in 774 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | Shanghai 10th People's Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 774 |
| Start date | 1 October 2020 |
| Primary completion | 31 December 2027 |
| Estimated completion | 30 June 2028 |
| Sites | 5 locations across China |
Drugs / interventions tested
- Continuous Electronic Monitor
Conditions studied
- Atrial Fibrillation New Onset — all drugs for Atrial Fibrillation New Onset →
- Acute Myocardial Infarction — all drugs for Acute Myocardial Infarction →
Sponsor
Shanghai 10th People's Hospital
Who can join
18 and older, any sex, with Atrial Fibrillation New Onset or Acute Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To validate the prognostic importance of the burden of new-onset atrial fibrillation (NOAF) complicating acute myocardial infarction (AMI) in a prospectively designed hospital-based registry. To characterize those factors that contribute to the progression of post-MI NOAF burden. To establish a prediction model for the risk stratification of patients with NOAF complicating AMI. To explore the clinical usefulness of NOAF burden in guiding the anticoagulation therapy among patients with post-MI NOAF.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04528511
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atrial Fibrillation New Onset
Currently open trials in the same condition.
- NCT05841056 — Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial · Phase 3 · recruiting
- NCT06275503 — STROKESTOP III - Optimized Method for Atrial Fibrillation Screening · NA · recruiting
- NCT06159985 — Effect of Left Posterior Pericardiotomy for the Prevention of POAF · NA · recruiting
- NCT05444335 — Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years · NA · active not recruiting
- NCT05229211 — Tracking Atrial Fibrillation After Intensive Care Admission · recruiting
Other Shanghai 10th People's Hospital trials
Trials by the same sponsor.
- NCT07528040 — An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With C · not yet recruiting
- NCT07370441 — Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients · Phase 4 · not yet recruiting
- NCT07328100 — Efficacy and Safety of Coenzyme I for Injection on Vascular Aging. · NA · not yet recruiting
- NCT06783296 — Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension · NA · not yet recruiting
- NCT07204496 — A Clinical Study on the Safety, Tolerance, and Preliminary Efficacy of γδ-T Cell Injection in the Treatment of Advanced · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04528511 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai 10th People's Hospital
- Last refreshed: 19 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04528511.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing